BAL PHARMA
Back to Cashflow Statement
|
BAL PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-15 Cr | ₹-19 Cr | ₹-22 Cr | ₹-9.48 Cr | ₹-5.53 Cr |
What is the latest Cash Flow from Investing Activities ratio of BAL PHARMA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-15 Cr |
| Mar2024 | ₹-19 Cr |
| Mar2023 | ₹-22 Cr |
| Mar2022 | ₹-9.48 Cr |
| Mar2021 | ₹-5.53 Cr |
How is Cash Flow from Investing Activities of BAL PHARMA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-15 Cr | Negative | |
| Mar2024 | ₹-19 Cr | Negative | |
| Mar2023 | ₹-22 Cr | Negative | |
| Mar2022 | ₹-9.48 Cr | Negative | |
| Mar2021 | ₹-5.53 Cr | - | |
Compare Cash Flow from Investing Activities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹119.0 Cr | -2.8% | 11.5% | -21.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -2.8% |
11.5% |
-21.7% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses